Trials / Conditions / Painful Diabetic Peripheral Neuropathy

Painful Diabetic Peripheral Neuropathy

10 registered clinical trials studyying Painful Diabetic Peripheral Neuropathy — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	High-frequency SCS Versus SCS in the Treatment of Diabetic Peripheral Neuropathic Pain NCT06158529	Fan BiFa	N/A
Completed	Exploratory Study of MT-8554 in Subjects With Painful Diabetic Peripheral Neuropathy NCT05123196	Tanabe Pharma Corporation	Phase 2
Completed	Ricolinostat in Patients With Painful Diabetic Peripheral Neuropathy NCT03176472	Regenacy Pharmaceuticals LLC	Phase 2
Terminated	Efficacy of Pregabalin and Duloxetine in Patients With PDPN: the Effect of Pain on Cognitive Function, Sleep a NCT04246619	KRKA	Phase 4
Unknown	Painful Diabetic Peripheral Neuropathy Study of Chinese OutPatiEnt NCT03520608	Peking University Third Hospital	—
Completed	Study to Assess the Efficacy, Safety and Tolerability of MT- 8554 in Subjects With Painful Diabetic Peripheral NCT03172598	Tanabe Pharma Corporation	Phase 2
Completed	A Clinical Trial to Study the Effects GRC 17536 in Patients With Painful Diabetic Peripheral Neuropathy (Painf NCT01726413	Glenmark Pharmaceuticals Ltd. India	Phase 2
Completed	Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Infla NCT01455415	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	Phase 3
Terminated	Examination of Pregabalin Access for Treatment of Indicated Pain Disorders: the ExPAND Study NCT01280747	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	—
Completed	Gene Therapy for Painful Diabetic Neuropathy NCT01002235	Helixmith Co., Ltd.	Phase 1 / Phase 2